BYSI on Nasdaq
BeyondSpring Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with CANNAPHARMARX, INC., Northwest Biotherapeutics or SciSparc, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-$19.8MFree cash flow3
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $0 | $0 |
| Research and development | -$4.4M | -$2.6M |
| General and administrative | -$4.6M | -$6.1M |
| Loss from operations | -$8.9M | -$8.8M |
| Foreign exchange gain (loss), net | $165.0K | -$96.0K |
| Interest income | $78.0K | $59.0K |
| Other income, net | $77.0K | $22.0K |
| Loss before income tax | -$8.6M | -$8.8M |
| Income tax expenses | -$90.0K | -$96.0K |
| Net loss from continuing operations | -$8.7M | -$8.9M |
| Loss from discontinued operations | -$12.5M | -$7.8M |
| Gain on disposal of discontinued operations | $7.0M | $0 |
| Income tax expenses | $0 | $0 |
| Net loss from discontinued operations | -$5.5M | -$7.8M |
| Net loss | -$14.2M | -$16.7M |
| Less: Net loss attributable to noncontrolling interests from continuing operations | -$242.0K | -$388.0K |
| Less: Net loss attributable to noncontrolling interests from discontinued operations | -$13.0M | -$5.2M |
| Net loss attributable to BeyondSpring Inc. | -$1.0M | -$11.1M |
| Continuing operations (in dollars per share) | -$0 | -$0 |
| Discontinued operations (in dollars per share) | -$0 | |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share (in dollars per share) | $0 | |
| Basic and diluted earnings (loss) per share (in dollars per share) | -$0.02 | -$0.28 |
| Basic and diluted (in shares) | 40.4M shares | 39.7M shares |
| Comprehensive loss | -$15.5M | -$16.0M |
| Comprehensive loss attributable to BeyondSpring Inc. | -$1.7M | -$10.7M |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $7.8M | $2.9M | |
| Short-term investments | $4.8M | $0 | |
| Advances to suppliers | $227.0K | $240.0K | |
| Prepaid expenses and other current assets | $71.0K | $68.0K | |
| Current assets of discontinued operations | $8.0M | $25.3M | |
| Total current assets | $20.9M | $28.6M | |
| Property and equipment, net | $166.0K | $239.0K | |
| Operating right-of-use assets | $305.0K | $513.0K | |
| Other noncurrent assets | $224.0K | $213.0K | |
| Noncurrent assets of discontinued operations | $4.4M | $4.8M | |
| Total noncurrent assets | $5.1M | $5.7M | |
| Total assets | $25.9M | $34.3M | |
| Accounts payable | $363.0K | $295.0K | |
| Accrued expenses | $938.0K | $840.0K | |
| Current portion of operating lease liabilities | $320.0K | $282.0K | |
| Other current liabilities | $822.0K | $780.0K | |
| Current liabilities of discontinued operations | $11.1M | $8.8M | |
| Total current liabilities | $13.6M | $11.0M | |
| Operating lease liabilities | $0 | $307.0K | |
| Deferred revenue | $28.6M | $27.4M | |
| Other noncurrent liabilities | $4.0M | $3.7M | |
| Noncurrent liabilities of discontinued operations | $3.8M | $6.2M | |
| Total noncurrent liabilities | $36.3M | $37.6M | |
| Total liabilities | $49.9M | $48.6M | |
| Ordinary shares ($0.0001 par value; 500,000,000 shares authorized; 40,316,320 and 41,122,320 shares issued and outstanding as of December 31, 2024 and 2025, respectively) | $4.0K | $4.0K | |
| Additional paid-in capital | $375.7M | $373.2M | |
| Accumulated deficit | -$408.4M | -$407.4M | |
| Accumulated other comprehensive income | $602.0K | $1.3M | |
| Total BeyondSpring Inc.s shareholders deficit | -$32.2M | -$32.9M | |
| Noncontrolling interests | $8.2M | $18.6M | |
| Total shareholders deficit | -$24.0M | -$14.3M | |
| Total liabilities and shareholders deficit | $25.9M | $34.3M | |
| Ordinary shares, par value (in dollars per share) | $0.00 | $0.00 | |
| Ordinary shares, authorized (in shares) | 500.0M shares | 500.0M shares | |
| Ordinary shares, issued (in shares) | 41.1M shares | 40.3M shares | |
| Common Stock, Shares, Outstanding (in shares) | 41.1M shares | 40.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$14.2M | -$16.7M |
| Depreciation expenses | $87.0K | $285.0K |
| Share-based compensation | $722.0K | $2.3M |
| Non-cash operating lease expenses | $747.0K | $702.0K |
| Unrealized gain on short-term investments | $0 | -$3.0K |
| Gain on sale of subsidiary interests | -$7.0M | $0 |
| Short-term investments | $254.0K | -$64.0K |
| Advances to suppliers | -$18.0K | -$19.0K |
| Prepaid expenses and other current assets | $64.0K | $10.0K |
| Other noncurrent assets | -$42.0K | -$117.0K |
| Accounts payable | -$76.0K | -$607.0K |
| Accrued expenses | $1.8M | -$387.0K |
| Operating lease liabilities | -$709.0K | -$631.0K |
| Other current liabilities | $268.0K | -$163.0K |
| Deferred revenue | -$2.0M | -$1.0M |
| Other noncurrent liabilities | $296.0K | -$10.0K |
| Net cash used in operating activities | -$19.8M | -$16.4M |
| Acquisitions of property and equipment | -$50.0K | -$224.0K |
| Purchase of short-term investments | -$14.9M | -$12.8M |
| Proceeds from maturity of short-term investments | $18.4M | $1.0M |
| Proceeds from sale of subsidiary interests | $7.4M | $0 |
| Net cash (used in) provided by investing activities | $10.8M | -$12.0M |
| Proceeds from issuance of ordinary shares | $2.0M | $3.0M |
| Capital contribution from noncontrolling interests | $2.7M | $20.0M |
| Proceeds from loans | $286.0K | $3.9M |
| Net cash provided by financing activities | $5.0M | $26.8M |
| Effect of foreign exchange rate changes | $105.0K | -$33.0K |
| Net decrease in cash and cash equivalents | -$3.9M | -$1.7M |
| Interest paid | $0 | $0 |
| Interest received | $311.0K | $148.0K |
| Income taxes paid | $2.0K | $7.0K |
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $40.0K | $0 |
| Issuance costs accrued in accrued expenses | $8.0K | $0 |
Recent filings
- Oct 13, 20268-K
- Oct 6, 20268-K
- Oct 2, 20268-K
- Sep 29, 2026424B5
- Sep 29, 20268-K
- Sep 18, 20268-K
- Sep 3, 2026ARS
- Sep 3, 2026DEF 14A DEFINITIVE PROXY STATEMENT
- Sep 3, 2026DEFA14A
- Aug 14, 20268-K
- Aug 14, 202610-Q
- Aug 14, 2026SCHEDULE 13G/A
- Jul 6, 20263
- Jul 6, 20263
- Jul 6, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10